BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12636872)

  • 1. Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
    Haas M; de Boer E; de Jong PE; Moolenaar F; Meijer DK; de Zeeuw D
    Clin Sci (Lond); 2003 Jul; 105(1):51-7. PubMed ID: 12636872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
    Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
    J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage.
    Kramer AB; Laverman GD; van Goor H; Navis G
    J Pathol; 2003 Sep; 201(1):160-7. PubMed ID: 12950029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.
    Bos H; Laverman GD; Henning RH; Tiebosch AT; de Jong PE; de Zeeuw D; Navis G
    J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):106-12. PubMed ID: 12806593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
    Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
    Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.
    Remuzzi A; Fassi A; Bertani T; Perico N; Remuzzi G
    Am J Kidney Dis; 1999 Oct; 34(4):626-32. PubMed ID: 10516341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy.
    Amara AB; Sharma A; Alexander JL; Alfirevic A; Mohiuddin A; Pirmohamed M; Close GL; Grime S; Maltby P; Shawki H; Heyworth S; Shenkin A; Smith L; Sharma AK; Hammad A; Rustom R
    Transplantation; 2010 Jan; 89(1):104-14. PubMed ID: 20061926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
    Bos H; Henning RH; De Boer E; Tiebosch AT; De Jong PE; De Zeeuw D; Navis G
    Kidney Int; 2002 Feb; 61(2):473-80. PubMed ID: 11849387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
    Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.
    Wapstra FH; Van Goor H; Navis G; De Jong PE; De Zeeuw D
    Clin Sci (Lond); 1996 May; 90(5):393-401. PubMed ID: 8665777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage.
    Rook M; Lely AT; Kramer AB; van Goor H; Navis G
    Nephrol Dial Transplant; 2005 Jan; 20(1):59-64. PubMed ID: 15572383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
    Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
    J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats.
    Waanders F; Greven WL; Baynes JW; Thorpe SR; Kramer AB; Nagai R; Sakata N; van Goor H; Navis G
    Nephrol Dial Transplant; 2005 Oct; 20(10):2060-70. PubMed ID: 15956058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does angiotensin (1-7) contribute to the anti-proteinuric effect of ACE-inhibitors.
    van der Wouden EA; Henning RH; Deelman LE; Roks AJ; Boomsma F; de Zeeuw D
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):96-101. PubMed ID: 16470489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G
    Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relativity of nuclear factor-kappaB (P65/Rel-A) and angiotensin II type 1 receptor expression in early stage of lesions of adriamycin nephrosis in young rats and the effects of intervention].
    Ma H; Li Z; Meng QH; Li XH; Wang XH; Li H; Li WW
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):275-9. PubMed ID: 15157388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.